Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6200178 | Ophthalmology | 2016 | 12 Pages |
Abstract
All active first-line drugs are effective compared with placebo in reducing IOP at 3 months. Bimatoprost, latanoprost, and travoprost are among the most efficacious drugs, although the within-class differences were small and may not be clinically meaningful. All factors, including adverse effects, patient preferences, and cost, should be considered in selecting a drug for a given patient.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Tianjing MD, PhD, Kristina MS, Benjamin MHS, Hwanhee PhD, Qiyuan MHS, David S. MD, PhD, Richard FRCOphth, Kay MA, PhD,